AVTX Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. (AVTX) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Caligan Partners Activist Event | Increased | +1.53M | +93.5% | $28.3M | 2.8% | 73 |
| Deep Track Capital Growth Healthcare | New | +3.61M | — | $66.7M | 1.0% | 71 |
| Affinity Asset Advisors Long/Short Growth | Increased | +1.56M | +116.3% | $28.8M | 2.7% | 67 |
| Braidwell Growth Healthcare | New | +1.63M | — | $30.1M | 1.2% | 66 |
| Baker Bros. Advisors Growth Healthcare | New | +550.0K | — | $10.2M | 0.1% | 65 |
| Vestal Point Capital Growth Healthcare | New | +775.0K | — | $14.3M | 0.3% | 64 |
| Nantahala Capital Management Event Long/Short | Increased | +2.49M | +201.6% | $46.0M | 2.2% | 62 |
| MILLENNIUM MANAGEMENT LLC | Sold Out | -835.5K | -100.0% | $15.4M | 0.0% | 61 |
| Soleus Capital Management Growth Healthcare | Increased | +1.21M | +274.4% | $22.4M | 1.1% | 60 |
| OrbiMed Advisors Growth Healthcare | Sold Out | -475.2K | -100.0% | $8.8M | 0.0% | 60 |
Most significant buyers
By move score, not size.
- Caligan Partners
- Deep Track Capital
- Affinity Asset Advisors
- Braidwell
- Baker Bros. Advisors
Most significant sellers
By move score, not size.
- MILLENNIUM MANAGEMENT LLC
- OrbiMed Advisors
- MARSHALL WACE, LLP
- Qube Research & Technologies Ltd
- Hudson Bay Capital Management
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Caligan Partners | 2 | 3.2M | 1.6M | +1.53M | +93.5% | 2.8% | Increased | 73 |
| Deep Track Capital | 1 | 3.6M | 0 | +3.61M | — | 1.0% | New | 71 |
| Affinity Asset Advisors | 2 | 2.9M | 1.3M | +1.56M | +116.3% | 2.7% | Increased | 67 |
| Braidwell | 2 | 1.6M | 0 | +1.63M | — | 1.2% | New | 66 |
| Baker Bros. Advisors | 1 | 550.0K | 0 | +550.0K | — | 0.1% | New | 65 |
| Vestal Point Capital | 1 | 775.0K | 0 | +775.0K | — | 0.3% | New | 64 |
| Nantahala Capital Management | 3 | 3.7M | 1.2M | +2.49M | +201.6% | 2.2% | Increased | 62 |
| MILLENNIUM MANAGEMENT LLC | 2 | 0 | 835.5K | -835.5K | -100.0% | 0.0% | Sold Out | 61 |
| Soleus Capital Management | 2 | 1.7M | 442.0K | +1.21M | +274.4% | 1.1% | Increased | 60 |
| OrbiMed Advisors | 2 | 0 | 475.2K | -475.2K | -100.0% | 0.0% | Sold Out | 60 |
| Farallon Capital Management | 1 | 2.5M | 916.0K | +1.58M | +172.7% | 0.3% | Increased | 59 |
| Logos Global Management | 2 | 1.2M | 300.0K | +850.0K | +283.3% | 0.9% | Increased | 58 |
| MARSHALL WACE, LLP | 2 | 0 | 129.1K | -129.1K | -100.0% | 0.0% | Sold Out | 58 |
| Point72 Asset Management, L.P. | 1 | 2.4M | 916.1K | +1.47M | +160.6% | 0.1% | Increased | 58 |
| Qube Research & Technologies Ltd | 2 | 0 | 174.5K | -174.5K | -100.0% | 0.0% | Sold Out | 57 |
| Hudson Bay Capital Management | 3 | 0 | 161.1K | -161.1K | -100.0% | 0.0% | Sold Out | 55 |
| RTW Investments | 1 | 175.0K | 857.0K | -682.0K | -79.6% | 0.0% | Reduced | 55 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 357.2K | 120.1K | +237.1K | +197.4% | 0.0% | Increased | 54 |
| Woodline Partners LP | 2 | 12.5K | 0 | +12.5K | — | 0.0% | New | 54 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 1.7M | 854.0K | +875.0K | +102.5% | 0.0% | Increased | 54 |
| Verition Fund Management | 2 | 38.2K | 0 | +38.2K | — | 0.0% | New | 54 |
| Walleye Capital | 3 | 185.6K | 0 | +185.6K | — | 0.0% | New | 53 |
| Schonfeld Strategic Advisors | 3 | 310.0K | 0 | +310.0K | — | 0.0% | New | 53 |
| Avoro Capital Advisors | 1 | 2.3M | 1.4M | +923.3K | +65.5% | 0.4% | Increased | 52 |
| Jain Global | 3 | 12.7K | 0 | +12.7K | — | 0.0% | New | 52 |
| CenterBook Partners | 4 | 132.9K | 0 | +132.9K | — | 0.1% | New | 51 |
| Squarepoint Ops LLC | 2 | 589.2K | 81.3K | +508.0K | +624.9% | 0.0% | Increased | 51 |
| Brevan Howard Capital Management | 3 | 0 | 19.3K | -19.3K | -100.0% | 0.0% | Sold Out | 49 |
| Aquatic Capital Management | 4 | 0 | 29.7K | -29.7K | -100.0% | 0.0% | Sold Out | 48 |
| Boothbay Fund Management | 4 | 702.1K | 324.3K | +377.8K | +116.5% | 0.3% | Increased | 46 |
| Perceptive Advisors | 1 | 219.8K | 139.7K | +80.1K | +57.4% | 0.1% | Increased | 46 |
| CITADEL ADVISORS LLC | 1 | 323.8K | 193.7K | +130.1K | +67.2% | 0.0% | Increased | 46 |
| Quadrature Capital | 3 | 15.4K | 125.2K | -109.8K | -87.7% | 0.0% | Reduced | 46 |
| RA Capital Management | 1 | 1.0M | 663.0K | +337.0K | +50.8% | 0.2% | Increased | 46 |
| Biotechnology Value Fund | 1 | 2.1M | 1.6M | +442.7K | +27.1% | 1.0% | Increased | 41 |
| Caption Management | 3 | 210.0K | 455.0K | -245.0K | -53.8% | 0.1% | Reduced | 36 |
| Balyasny Asset Management L.P. | 2 | 861.7K | 731.6K | +130.1K | +17.8% | 0.0% | Increased | 33 |
| TWO SIGMA INVESTMENTS, LP | 2 | 67.1K | 64.4K | +2.7K | +4.1% | 0.0% | Increased | 27 |
| Man Group | 3 | 36.9K | 46.6K | -9.7K | -20.8% | 0.0% | Reduced | 26 |
| ExodusPoint Capital Management | 3 | 16.5K | 17.8K | -1.3K | -7.1% | 0.0% | Reduced | 23 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.